sodium;azane;carbanide;3-[1-(4-chloropyrimidin-2-yl)-3-propan-2-ylpyrazol-4-yl]-1,2-oxazole;deuterium monohydride;ethyl 2-fluoroprop-2-enoate;ethyl 1-[(4-methoxyphenyl)methyl]-3-propan-2-ylpyrazole-4-carboxylate;ethyl 4-methyl-3-oxopentanoate;ethyl 5-propan-2-yl-1H-pyrazole-4-carboxylate;2-methylpropanoic acid;4-(1,2-oxazol-3-yl)-3-propan-2-ylpyrazole-1-carboximidamide;2-[4-(1,2-oxazol-3-yl)-3-propan-2-ylpyrazol-1-yl]pyrimidin-4-amine;2-[4-(1,2-oxazol-3-yl)-3-propan-2-ylpyrazol-1-yl]-1H-pyrimidin-6-one;3-(5-propan-2-yl-1H-pyrazol-4-yl)-1,2-oxazole;nonakis(tungsten(2+));hydroxide

C110H151ClFN29NaO19W9- — CID 161036815

IUPACsodium;azane;carbanide;3-[1-(4-chloropyrimidin-2-yl)-3-propan-2-ylpyrazol-4-yl]-1,2-oxazole;deuterium monohydride;ethyl 2-fluoroprop-2-enoate;ethyl 1-[(4-methoxyphenyl)methyl]-3-propan-2-ylpyrazole-4-carboxylate;ethyl 4-methyl-3-oxopentanoate;ethyl 5-propan-2-yl-1H-pyrazole-4-carboxylate;2-methylpropanoic acid;4-(1,2-oxazol-3-yl)-3-propan-2-ylpyrazole-1-carboximidamide;2-[4-(1,2-oxazol-3-yl)-3-propan-2-ylpyrazol-1-yl]pyrimidin-4-amine;2-[4-(1,2-oxazol-3-yl)-3-propan-2-ylpyrazol-1-yl]-1H-pyrimidin-6-one;3-(5-propan-2-yl-1H-pyrazol-4-yl)-1,2-oxazole;nonakis(tungsten(2+));hydroxide
SMILESCCOC(=O)CC(=O)[C-](C)C.CCOC(=O)c1cn(Cc2ccc(OC)cc2)nc1[C-](C)C.CCOC(=O)c1cn[nH]c1[C-](C)C.C[C-](C)C(=O)O.C[C-](C)c1[nH]ncc1-c1ccon1.C[C-](C)c1nn(-c2nccc(=O)[nH]2)cc1-c1ccon1.C[C-](C)c1nn(-c2nccc(Cl)n2)cc1-c1ccon1.C[C-](C)c1nn(-c2nccc(N)n2)cc1-c1ccon1.N.[CH3-].[CH3-].[CH3-].[CH3-].[CH3-].[CH3-].[CH3-].[CH3-].[CH3-].[H]/N=C(\N)n1cc(-c2ccon2)c([C-](C)C)n1.[H]/[C-]=C(/F)C(=O)OCC.[H][2H].[Na+].[OH-].[W+2].[W+2].[W+2].[W+2].[W+2].[W+2].[W+2].[W+2].[W+2]
InChIInChI=1S/C17H21N2O3.C13H11ClN5O.C13H13N6O.C13H12N5O2.C10H12N5O.C9H10N3O.C9H13N2O2.C8H13O3.C5H6FO2.C4H7O2.9CH3.H3N.Na.H2O.9W.H2/c1-5-22-17(20)15-11-19(18-16(15)12(2)3)10-13-6-8-14(21-4)9-7-13;2*1-8(2)12-9(10-4-6-20-18-10)7-19(17-12)13-15-5-3-11(14)16-13;1-8(2)12-9(10-4-6-20-17-10)7-18(16-12)13-14-5-3-11(19)15-13;1-6(2)9-7(8-3-4-16-14-8)5-15(13-9)10(11)12;1-6(2)9-7(5-10-11-9)8-3-4-13-12-8;1-4-13-9(12)7-5-10-11-8(7)6(2)3;1-4-11-8(10)5-7(9)6(2)3;1-3-8-5(7)4(2)6;1-3(2)4(5)6;;;;;;;;;;;;;;;;;;;;;;/h6-9,11H,5,10H2,1-4H3;3-7H,1-2H3;3-7H,1-2H3,(H2,14,15,16);3-7H,1-2H3,(H,14,15,19);3-5H,1-2H3,(H3,11,12);3-5H,1-2H3,(H,10,11);5H,4H2,1-3H3,(H,10,11);4-5H2,1-3H3;2H,3H2,1H3;1-2H3,(H,5,6);10*1H3;;1H2;;;;;;;;;;1H/q19*-1;;+1;;9*+2;/p-1/i;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;1+1
InChIKeyHYKATNHWPFUGTL-SGXDLNDDSA-M
MW3916.61 g/mol
LogP18.17
Rot. Bonds29

About sodium;azane;carbanide;3-[1-(4-chloropyrimidin-2-yl)-3-propan-2-ylpyrazol-4-yl]-1,2-oxazole;deuterium monohydride;ethyl 2-fluoroprop-2-enoate;ethyl 1-[(4-methoxyphenyl)methyl]-3-propan-2-ylpyrazole-4-carboxylate;ethyl 4-methyl-3-oxopentanoate;ethyl 5-propan-2-yl-1H-pyrazole-4-carboxylate;2-methylpropanoic acid;4-(1,2-oxazol-3-yl)-3-propan-2-ylpyrazole-1-carboximidamide;2-[4-(1,2-oxazol-3-yl)-3-propan-2-ylpyrazol-1-yl]pyrimidin-4-amine;2-[4-(1,2-oxazol-3-yl)-3-propan-2-ylpyrazol-1-yl]-1H-pyrimidin-6-one;3-(5-propan-2-yl-1H-pyrazol-4-yl)-1,2-oxazole;nonakis(tungsten(2+));hydroxide

sodium;azane;carbanide;3-[1-(4-chloropyrimidin-2-yl)-3-propan-2-ylpyrazol-4-yl]-1,2-oxazole;deuterium monohydride;ethyl 2-fluoroprop-2-enoate;ethyl 1-[(4-methoxyphenyl)methyl]-3-propan-2-ylpyrazole-4-carboxylate;ethyl 4-methyl-3-oxopentanoate;ethyl 5-propan-2-yl-1H-pyrazole-4-carboxylate;2-methylpropanoic acid;4-(1,2-oxazol-3-yl)-3-propan-2-ylpyrazole-1-carboximidamide;2-[4-(1,2-oxazol-3-yl)-3-propan-2-ylpyrazol-1-yl]pyrimidin-4-amine;2-[4-(1,2-oxazol-3-yl)-3-propan-2-ylpyrazol-1-yl]-1H-pyrimidin-6-one;3-(5-propan-2-yl-1H-pyrazol-4-yl)-1,2-oxazole;nonakis(tungsten(2+));hydroxide (PubChem CID 161036815) has the molecular formula C110H151ClFN29NaO19W9- and a molecular weight of 3916.61 g/mol. Its IUPAC name is sodium;azane;carbanide;3-[1-(4-chloropyrimidin-2-yl)-3-propan-2-ylpyrazol-4-yl]-1,2-oxazole;deuterium monohydride;ethyl 2-fluoroprop-2-enoate;ethyl 1-[(4-methoxyphenyl)methyl]-3-propan-2-ylpyrazole-4-carboxylate;ethyl 4-methyl-3-oxopentanoate;ethyl 5-propan-2-yl-1H-pyrazole-4-carboxylate;2-methylpropanoic acid;4-(1,2-oxazol-3-yl)-3-propan-2-ylpyrazole-1-carboximidamide;2-[4-(1,2-oxazol-3-yl)-3-propan-2-ylpyrazol-1-yl]pyrimidin-4-amine;2-[4-(1,2-oxazol-3-yl)-3-propan-2-ylpyrazol-1-yl]-1H-pyrimidin-6-one;3-(5-propan-2-yl-1H-pyrazol-4-yl)-1,2-oxazole;nonakis(tungsten(2+));hydroxide.

Molecular Properties

Compound Namesodium;azane;carbanide;3-[1-(4-chloropyrimidin-2-yl)-3-propan-2-ylpyrazol-4-yl]-1,2-oxazole;deuterium monohydride;ethyl 2-fluoroprop-2-enoate;ethyl 1-[(4-methoxyphenyl)methyl]-3-propan-2-ylpyrazole-4-carboxylate;ethyl 4-methyl-3-oxopentanoate;ethyl 5-propan-2-yl-1H-pyrazole-4-carboxylate;2-methylpropanoic acid;4-(1,2-oxazol-3-yl)-3-propan-2-ylpyrazole-1-carboximidamide;2-[4-(1,2-oxazol-3-yl)-3-propan-2-ylpyrazol-1-yl]pyrimidin-4-amine;2-[4-(1,2-oxazol-3-yl)-3-propan-2-ylpyrazol-1-yl]-1H-pyrimidin-6-one;3-(5-propan-2-yl-1H-pyrazol-4-yl)-1,2-oxazole;nonakis(tungsten(2+));hydroxide
PubChem CID161036815
Molecular FormulaC110H151ClFN29NaO19W9-
Molecular Weight3916.61 g/mol
Exact Mass3915.70
IUPAC Namesodium;azane;carbanide;3-[1-(4-chloropyrimidin-2-yl)-3-propan-2-ylpyrazol-4-yl]-1,2-oxazole;deuterium monohydride;ethyl 2-fluoroprop-2-enoate;ethyl 1-[(4-methoxyphenyl)methyl]-3-propan-2-ylpyrazole-4-carboxylate;ethyl 4-methyl-3-oxopentanoate;ethyl 5-propan-2-yl-1H-pyrazole-4-carboxylate;2-methylpropanoic acid;4-(1,2-oxazol-3-yl)-3-propan-2-ylpyrazole-1-carboximidamide;2-[4-(1,2-oxazol-3-yl)-3-propan-2-ylpyrazol-1-yl]pyrimidin-4-amine;2-[4-(1,2-oxazol-3-yl)-3-propan-2-ylpyrazol-1-yl]-1H-pyrimidin-6-one;3-(5-propan-2-yl-1H-pyrazol-4-yl)-1,2-oxazole;nonakis(tungsten(2+));hydroxide
SMILESCCOC(=O)CC(=O)[C-](C)C.CCOC(=O)c1cn(Cc2ccc(OC)cc2)nc1[C-](C)C.CCOC(=O)c1cn[nH]c1[C-](C)C.C[C-](C)C(=O)O.C[C-](C)c1[nH]ncc1-c1ccon1.C[C-](C)c1nn(-c2nccc(=O)[nH]2)cc1-c1ccon1.C[C-](C)c1nn(-c2nccc(Cl)n2)cc1-c1ccon1.C[C-](C)c1nn(-c2nccc(N)n2)cc1-c1ccon1.N.[CH3-].[CH3-].[CH3-].[CH3-].[CH3-].[CH3-].[CH3-].[CH3-].[CH3-].[H]/N=C(\N)n1cc(-c2ccon2)c([C-](C)C)n1.[H]/[C-]=C(/F)C(=O)OCC.[H][2H].[Na+].[OH-].[W+2].[W+2].[W+2].[W+2].[W+2].[W+2].[W+2].[W+2].[W+2]
InChIInChI=1S/C17H21N2O3.C13H11ClN5O.C13H13N6O.C13H12N5O2.C10H12N5O.C9H10N3O.C9H13N2O2.C8H13O3.C5H6FO2.C4H7O2.9CH3.H3N.Na.H2O.9W.H2/c1-5-22-17(20)15-11-19(18-16(15)12(2)3)10-13-6-8-14(21-4)9-7-13;2*1-8(2)12-9(10-4-6-20-18-10)7-19(17-12)13-15-5-3-11(14)16-13;1-8(2)12-9(10-4-6-20-17-10)7-18(16-12)13-14-5-3-11(19)15-13;1-6(2)9-7(8-3-4-16-14-8)5-15(13-9)10(11)12;1-6(2)9-7(5-10-11-9)8-3-4-13-12-8;1-4-13-9(12)7-5-10-11-8(7)6(2)3;1-4-11-8(10)5-7(9)6(2)3;1-3-8-5(7)4(2)6;1-3(2)4(5)6;;;;;;;;;;;;;;;;;;;;;;/h6-9,11H,5,10H2,1-4H3;3-7H,1-2H3;3-7H,1-2H3,(H2,14,15,16);3-7H,1-2H3,(H,14,15,19);3-5H,1-2H3,(H3,11,12);3-5H,1-2H3,(H,10,11);5H,4H2,1-3H3,(H,10,11);4-5H2,1-3H3;2H,3H2,1H3;1-2H3,(H,5,6);10*1H3;;1H2;;;;;;;;;;1H/q19*-1;;+1;;9*+2;/p-1/i;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;1+1
InChIKeyHYKATNHWPFUGTL-SGXDLNDDSA-M
XLogP18.17
TPSA683.61 Ų
H-Bond Donors8
H-Bond Acceptors43
Rotatable Bonds29
Heavy Atoms170
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5003916.61
LogP ≤ 518.17
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1043

Computed Properties (RDKit)

Structural Alerts{'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'beta-keto/anhydride', 'substructure': 'N/A'}, {'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'}

Analyze sodium;azane;carbanide;3-[1-(4-chloropyrimidin-2-yl)-3-propan-2-ylpyrazol-4-yl]-1,2-oxazole;deuterium monohydride;ethyl 2-fluoroprop-2-enoate;ethyl 1-[(4-methoxyphenyl)methyl]-3-propan-2-ylpyrazole-4-carboxylate;ethyl 4-methyl-3-oxopentanoate;ethyl 5-propan-2-yl-1H-pyrazole-4-carboxylate;2-methylpropanoic acid;4-(1,2-oxazol-3-yl)-3-propan-2-ylpyrazole-1-carboximidamide;2-[4-(1,2-oxazol-3-yl)-3-propan-2-ylpyrazol-1-yl]pyrimidin-4-amine;2-[4-(1,2-oxazol-3-yl)-3-propan-2-ylpyrazol-1-yl]-1H-pyrimidin-6-one;3-(5-propan-2-yl-1H-pyrazol-4-yl)-1,2-oxazole;nonakis(tungsten(2+));hydroxide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

sodium;azane;carbanide;4-chloro-2-(4-methyl-3-propan-2-ylpyrazol-1-yl)pyrimidine;deuterium monohydride;ethyl 2-fluoroprop-2-enoate;ethyl 1-[(4-methoxyphenyl)methyl]-3-propan-2-ylpyrazole-4-carboxylate;4-iodo-1-[(4-methoxyphenyl)methyl]-3-propan-2-ylpyrazole;methane;1-[(4-methoxyphenyl)methyl]-4-methyl-3-propan-2-ylpyrazole;1-[(4-methoxyphenyl)methyl]-3-propan-2-ylpyrazol-4-amine;1-[(4-methoxyphenyl)methyl]-3-propan-2-ylpyrazole-4-carboxylic acid;4-methyl-5-propan-2-yl-1H-pyrazole;4-methyl-3-propan-2-ylpyrazole-1-carboximidamide;2-(4-methyl-3-propan-2-ylpyrazol-1-yl)pyrimidin-4-amine;2-(4-methyl-3-propan-2-ylpyrazol-1-yl)-1H-pyrimidin-6-one;decakis(tungsten(2+));hydroxide
CID 157350554
sodium;azane;carbanide;3-[1-(4-chloropyrimidin-2-yl)-3-propan-2-ylpyrazol-4-yl]-1,2-oxazole;deuterium monohydride;ethyl 2-fluoroprop-2-enoate;ethyl 1-[(4-methoxyphenyl)methyl]-3-propan-2-ylpyrazole-4-carboxylate;ethyl 4-methyl-3-oxopentanoate;ethyl 5-propan-2-yl-1H-pyrazole-4-carboxylate;methane;2-methylpropanoic acid;4-(1,2-oxazol-3-yl)-3-propan-2-ylpyrazole-1-carboximidamide;2-[4-(1,2-oxazol-3-yl)-3-propan-2-ylpyrazol-1-yl]pyrimidin-4-amine;2-[4-(1,2-oxazol-3-yl)-3-propan-2-ylpyrazol-1-yl]-1H-pyrimidin-6-one;3-(5-propan-2-yl-1H-pyrazol-4-yl)-1,2-oxazole;nonakis(tungsten(2+));hydroxide
CID 158949448
sodium;azane;carbanide;4-chloro-2-(4-methyl-3-propan-2-ylpyrazol-1-yl)pyrimidine;deuterium monohydride;ethyl 2-fluoroprop-2-enoate;ethyl 1-[(4-methoxyphenyl)methyl]-3-propan-2-ylpyrazole-4-carboxylate;4-iodo-1-[(4-methoxyphenyl)methyl]-3-propan-2-ylpyrazole;methane;1-[(4-methoxyphenyl)methyl]-4-methyl-3-propan-2-ylpyrazole;1-[(4-methoxyphenyl)methyl]-3-propan-2-ylpyrazol-4-amine;1-[(4-methoxyphenyl)methyl]-3-propan-2-ylpyrazole-4-carboxylic acid;methylboronic acid;4-methyl-5-propan-2-yl-1H-pyrazole;4-methyl-3-propan-2-ylpyrazole-1-carboximidamide;2-(4-methyl-3-propan-2-ylpyrazol-1-yl)pyrimidin-4-amine;2-(4-methyl-3-propan-2-ylpyrazol-1-yl)-1H-pyrimidin-6-one;decakis(tungsten(2+));hydroxide
CID 161484477

Frequently Asked Questions

What is the IUPAC name of sodium;azane;carbanide;3-[1-(4-chloropyrimidin-2-yl)-3-propan-2-ylpyrazol-4-yl]-1,2-oxazole;deuterium monohydride;ethyl 2-fluoroprop-2-enoate;ethyl 1-[(4-methoxyphenyl)methyl]-3-propan-2-ylpyrazole-4-carboxylate;ethyl 4-methyl-3-oxopentanoate;ethyl 5-propan-2-yl-1H-pyrazole-4-carboxylate;2-methylpropanoic acid;4-(1,2-oxazol-3-yl)-3-propan-2-ylpyrazole-1-carboximidamide;2-[4-(1,2-oxazol-3-yl)-3-propan-2-ylpyrazol-1-yl]pyrimidin-4-amine;2-[4-(1,2-oxazol-3-yl)-3-propan-2-ylpyrazol-1-yl]-1H-pyrimidin-6-one;3-(5-propan-2-yl-1H-pyrazol-4-yl)-1,2-oxazole;nonakis(tungsten(2+));hydroxide?
The IUPAC name of sodium;azane;carbanide;3-[1-(4-chloropyrimidin-2-yl)-3-propan-2-ylpyrazol-4-yl]-1,2-oxazole;deuterium monohydride;ethyl 2-fluoroprop-2-enoate;ethyl 1-[(4-methoxyphenyl)methyl]-3-propan-2-ylpyrazole-4-carboxylate;ethyl 4-methyl-3-oxopentanoate;ethyl 5-propan-2-yl-1H-pyrazole-4-carboxylate;2-methylpropanoic acid;4-(1,2-oxazol-3-yl)-3-propan-2-ylpyrazole-1-carboximidamide;2-[4-(1,2-oxazol-3-yl)-3-propan-2-ylpyrazol-1-yl]pyrimidin-4-amine;2-[4-(1,2-oxazol-3-yl)-3-propan-2-ylpyrazol-1-yl]-1H-pyrimidin-6-one;3-(5-propan-2-yl-1H-pyrazol-4-yl)-1,2-oxazole;nonakis(tungsten(2+));hydroxide (CID 161036815) is sodium;azane;carbanide;3-[1-(4-chloropyrimidin-2-yl)-3-propan-2-ylpyrazol-4-yl]-1,2-oxazole;deuterium monohydride;ethyl 2-fluoroprop-2-enoate;ethyl 1-[(4-methoxyphenyl)methyl]-3-propan-2-ylpyrazole-4-carboxylate;ethyl 4-methyl-3-oxopentanoate;ethyl 5-propan-2-yl-1H-pyrazole-4-carboxylate;2-methylpropanoic acid;4-(1,2-oxazol-3-yl)-3-propan-2-ylpyrazole-1-carboximidamide;2-[4-(1,2-oxazol-3-yl)-3-propan-2-ylpyrazol-1-yl]pyrimidin-4-amine;2-[4-(1,2-oxazol-3-yl)-3-propan-2-ylpyrazol-1-yl]-1H-pyrimidin-6-one;3-(5-propan-2-yl-1H-pyrazol-4-yl)-1,2-oxazole;nonakis(tungsten(2+));hydroxide.
What is the SMILES notation for sodium;azane;carbanide;3-[1-(4-chloropyrimidin-2-yl)-3-propan-2-ylpyrazol-4-yl]-1,2-oxazole;deuterium monohydride;ethyl 2-fluoroprop-2-enoate;ethyl 1-[(4-methoxyphenyl)methyl]-3-propan-2-ylpyrazole-4-carboxylate;ethyl 4-methyl-3-oxopentanoate;ethyl 5-propan-2-yl-1H-pyrazole-4-carboxylate;2-methylpropanoic acid;4-(1,2-oxazol-3-yl)-3-propan-2-ylpyrazole-1-carboximidamide;2-[4-(1,2-oxazol-3-yl)-3-propan-2-ylpyrazol-1-yl]pyrimidin-4-amine;2-[4-(1,2-oxazol-3-yl)-3-propan-2-ylpyrazol-1-yl]-1H-pyrimidin-6-one;3-(5-propan-2-yl-1H-pyrazol-4-yl)-1,2-oxazole;nonakis(tungsten(2+));hydroxide?
The canonical SMILES for sodium;azane;carbanide;3-[1-(4-chloropyrimidin-2-yl)-3-propan-2-ylpyrazol-4-yl]-1,2-oxazole;deuterium monohydride;ethyl 2-fluoroprop-2-enoate;ethyl 1-[(4-methoxyphenyl)methyl]-3-propan-2-ylpyrazole-4-carboxylate;ethyl 4-methyl-3-oxopentanoate;ethyl 5-propan-2-yl-1H-pyrazole-4-carboxylate;2-methylpropanoic acid;4-(1,2-oxazol-3-yl)-3-propan-2-ylpyrazole-1-carboximidamide;2-[4-(1,2-oxazol-3-yl)-3-propan-2-ylpyrazol-1-yl]pyrimidin-4-amine;2-[4-(1,2-oxazol-3-yl)-3-propan-2-ylpyrazol-1-yl]-1H-pyrimidin-6-one;3-(5-propan-2-yl-1H-pyrazol-4-yl)-1,2-oxazole;nonakis(tungsten(2+));hydroxide is CCOC(=O)CC(=O)[C-](C)C.CCOC(=O)c1cn(Cc2ccc(OC)cc2)nc1[C-](C)C.CCOC(=O)c1cn[nH]c1[C-](C)C.C[C-](C)C(=O)O.C[C-](C)c1[nH]ncc1-c1ccon1.C[C-](C)c1nn(-c2nccc(=O)[nH]2)cc1-c1ccon1.C[C-](C)c1nn(-c2nccc(Cl)n2)cc1-c1ccon1.C[C-](C)c1nn(-c2nccc(N)n2)cc1-c1ccon1.N.[CH3-].[CH3-].[CH3-].[CH3-].[CH3-].[CH3-].[CH3-].[CH3-].[CH3-].[H]/N=C(\N)n1cc(-c2ccon2)c([C-](C)C)n1.[H]/[C-]=C(/F)C(=O)OCC.[H][2H].[Na+].[OH-].[W+2].[W+2].[W+2].[W+2].[W+2].[W+2].[W+2].[W+2].[W+2].
What is the InChIKey of sodium;azane;carbanide;3-[1-(4-chloropyrimidin-2-yl)-3-propan-2-ylpyrazol-4-yl]-1,2-oxazole;deuterium monohydride;ethyl 2-fluoroprop-2-enoate;ethyl 1-[(4-methoxyphenyl)methyl]-3-propan-2-ylpyrazole-4-carboxylate;ethyl 4-methyl-3-oxopentanoate;ethyl 5-propan-2-yl-1H-pyrazole-4-carboxylate;2-methylpropanoic acid;4-(1,2-oxazol-3-yl)-3-propan-2-ylpyrazole-1-carboximidamide;2-[4-(1,2-oxazol-3-yl)-3-propan-2-ylpyrazol-1-yl]pyrimidin-4-amine;2-[4-(1,2-oxazol-3-yl)-3-propan-2-ylpyrazol-1-yl]-1H-pyrimidin-6-one;3-(5-propan-2-yl-1H-pyrazol-4-yl)-1,2-oxazole;nonakis(tungsten(2+));hydroxide?
The InChIKey is HYKATNHWPFUGTL-SGXDLNDDSA-M. The full InChI is InChI=1S/C17H21N2O3.C13H11ClN5O.C13H13N6O.C13H12N5O2.C10H12N5O.C9H10N3O.C9H13N2O2.C8H13O3.C5H6FO2.C4H7O2.9CH3.H3N.Na.H2O.9W.H2/c1-5-22-17(20)15-11-19(18-16(15)12(2)3)10-13-6-8-14(21-4)9-7-13;2*1-8(2)12-9(10-4-6-20-18-10)7-19(17-12)13-15-5-3-11(14)16-13;1-8(2)12-9(10-4-6-20-17-10)7-18(16-12)13-14-5-3-11(19)15-13;1-6(2)9-7(8-3-4-16-14-8)5-15(13-9)10(11)12;1-6(2)9-7(5-10-11-9)8-3-4-13-12-8;1-4-13-9(12)7-5-10-11-8(7)6(2)3;1-4-11-8(10)5-7(9)6(2)3;1-3-8-5(7)4(2)6;1-3(2)4(5)6;;;;;;;;;;;;;;;;;;;;;;/h6-9,11H,5,10H2,1-4H3;3-7H,1-2H3;3-7H,1-2H3,(H2,14,15,16);3-7H,1-2H3,(H,14,15,19);3-5H,1-2H3,(H3,11,12);3-5H,1-2H3,(H,10,11);5H,4H2,1-3H3,(H,10,11);4-5H2,1-3H3;2H,3H2,1H3;1-2H3,(H,5,6);10*1H3;;1H2;;;;;;;;;;1H/q19*-1;;+1;;9*+2;/p-1/i;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;1+1.
What are the key properties of sodium;azane;carbanide;3-[1-(4-chloropyrimidin-2-yl)-3-propan-2-ylpyrazol-4-yl]-1,2-oxazole;deuterium monohydride;ethyl 2-fluoroprop-2-enoate;ethyl 1-[(4-methoxyphenyl)methyl]-3-propan-2-ylpyrazole-4-carboxylate;ethyl 4-methyl-3-oxopentanoate;ethyl 5-propan-2-yl-1H-pyrazole-4-carboxylate;2-methylpropanoic acid;4-(1,2-oxazol-3-yl)-3-propan-2-ylpyrazole-1-carboximidamide;2-[4-(1,2-oxazol-3-yl)-3-propan-2-ylpyrazol-1-yl]pyrimidin-4-amine;2-[4-(1,2-oxazol-3-yl)-3-propan-2-ylpyrazol-1-yl]-1H-pyrimidin-6-one;3-(5-propan-2-yl-1H-pyrazol-4-yl)-1,2-oxazole;nonakis(tungsten(2+));hydroxide?
sodium;azane;carbanide;3-[1-(4-chloropyrimidin-2-yl)-3-propan-2-ylpyrazol-4-yl]-1,2-oxazole;deuterium monohydride;ethyl 2-fluoroprop-2-enoate;ethyl 1-[(4-methoxyphenyl)methyl]-3-propan-2-ylpyrazole-4-carboxylate;ethyl 4-methyl-3-oxopentanoate;ethyl 5-propan-2-yl-1H-pyrazole-4-carboxylate;2-methylpropanoic acid;4-(1,2-oxazol-3-yl)-3-propan-2-ylpyrazole-1-carboximidamide;2-[4-(1,2-oxazol-3-yl)-3-propan-2-ylpyrazol-1-yl]pyrimidin-4-amine;2-[4-(1,2-oxazol-3-yl)-3-propan-2-ylpyrazol-1-yl]-1H-pyrimidin-6-one;3-(5-propan-2-yl-1H-pyrazol-4-yl)-1,2-oxazole;nonakis(tungsten(2+));hydroxide has a molecular weight of 3916.61 g/mol, XLogP of 18.17, 29 rotatable bonds, 8 hydrogen bond donors, and 43 hydrogen bond acceptors.
Where does this data come from?
All data for sodium;azane;carbanide;3-[1-(4-chloropyrimidin-2-yl)-3-propan-2-ylpyrazol-4-yl]-1,2-oxazole;deuterium monohydride;ethyl 2-fluoroprop-2-enoate;ethyl 1-[(4-methoxyphenyl)methyl]-3-propan-2-ylpyrazole-4-carboxylate;ethyl 4-methyl-3-oxopentanoate;ethyl 5-propan-2-yl-1H-pyrazole-4-carboxylate;2-methylpropanoic acid;4-(1,2-oxazol-3-yl)-3-propan-2-ylpyrazole-1-carboximidamide;2-[4-(1,2-oxazol-3-yl)-3-propan-2-ylpyrazol-1-yl]pyrimidin-4-amine;2-[4-(1,2-oxazol-3-yl)-3-propan-2-ylpyrazol-1-yl]-1H-pyrimidin-6-one;3-(5-propan-2-yl-1H-pyrazol-4-yl)-1,2-oxazole;nonakis(tungsten(2+));hydroxide is sourced from PubChem (CID 161036815), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).